Dementia Trials Australia

Dementia Trials Australia (DTA) is a national clinical trial network dedicated to accelerating the development of new treatments for dementia and Alzheimer's disease. The organization provides a streamlined, centralized infrastructure that connects global pharmaceutical and biotechnology sponsors with high-quality clinical trial sites across Australia. DTA offers a comprehensive suite of services, including site identification, feasibility assessments, participant recruitment support, and the implementation of standardized clinical protocols. By leveraging Australia's world-class research expertise and regulatory environment, DTA facilitates Phase 1 through Phase 3 trials for a wide range of therapeutic modalities. The network's primary goal is to increase the capacity for dementia research in the Asia-Pacific region and ensure that patients have early access to innovative, life-changing therapies.